Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Long-term survival and predictors of relapse and survival after liver transplantation for alcoholic liver disease.

Lindenger C, Castedal M, Schult A, Åberg F.

Scand J Gastroenterol. 2018 Dec;53(12):1553-1561. doi: 10.1080/00365521.2018.1536226.

PMID:
30678557
2.

Waist-to-hip ratio but not body mass index predicts liver cirrhosis in women.

Schult A, Mehlig K, Björkelund C, Wallerstedt S, Kaczynski J.

Scand J Gastroenterol. 2018 Feb;53(2):212-217. doi: 10.1080/00365521.2017.1420219. Epub 2017 Dec 25.

PMID:
29276897
3.

Sigmoidoscopy and faecal occult blood test - a comparative screening trial.

Lange T, Randel KR, Schult AL, Knudsen MD, Kirkøen B, Botteri E, Berstad P, Jørgensen A, Ursin G, Bretthauer M, Hoff G.

Tidsskr Nor Laegeforen. 2017 May 23;137(10):727-730. doi: 10.4045/tidsskr.16.1031. eCollection 2017 May. English, Norwegian. No abstract available.

4.

[Ascites is usually caused by an underlying liver cirrhosis. Salt restriction and diuretics is the basis for treatment].

Schult A, Friis-Liby I.

Lakartidningen. 2016 Mar 15;113. pii: DPCL. Review. Swedish.

5.

Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men.

Schult A, Eriksson H, Wallerstedt S, Kaczynski J.

Scand J Gastroenterol. 2011 Jun;46(6):738-44. doi: 10.3109/00365521.2011.560679. Epub 2011 Feb 28.

PMID:
21561285
6.

Complement C5 mediates experimental tubulointerstitial fibrosis.

Boor P, Konieczny A, Villa L, Schult AL, Bücher E, Rong S, Kunter U, van Roeyen CR, Polakowski T, Hawlisch H, Hillebrandt S, Lammert F, Eitner F, Floege J, Ostendorf T.

J Am Soc Nephrol. 2007 May;18(5):1508-15. Epub 2007 Mar 27.

7.

[Research on a pyramidon derivative without delayed action on a simultaneously administered anticoagulant coumarin derivative].

SCHULT A, GRUNDNER HG, HARTERT H.

Med Welt. 1962 Feb 10;6:312-4. German. No abstract available.

PMID:
13909474

Supplemental Content

Loading ...
Support Center